GV co-led a series C round for the healthcare collaboration service together with F-Prime Capital, Andreessen Horowitz and Transformation Capital, taking its overall funding past $101m.

The Legend Capital-backed auto parts e-commerce marketplace boosted its total funding to $110m in a $56.6m round led by Huaxing Growth Capital Fund.

Stanford’s lysosome protein degradation spinout Lycia emerged with $50m of capital from Versant Ventures to develop a portfolio of drug candidates.

Existing backer GV returned to take part in a $100m round for the Stanford spinout that also attracted new investor Regeneron Pharmaceuticals.

The bank digitisation software provider Nymbus has now raised more than $45m in total, Vensure Enterprise co-leading its latest round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Varian Medical Systems and Johnson & Johnson Innovation – JJDC have returned for the series C-1 round having backed the U-M spinout's series C last year.

Eli Lilly will collaborate on five drug candidates based on the Oxford and Karolinska Institute spinout's exosome delivery technology.

Existing backer GV returned to take part in a $100m round for the clinical data software provider that also attracted new investor Regeneron Pharmaceuticals.

Varian Medical Systems and Johnson & Johnson Innovation – JJDC returned for the series C-1 round having backed the histotripsy technology developer's series C last year.